Talaris Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Talaris Therapeutics has a total shareholder equity of $148.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $159.1M and $10.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$152.25m |
Equity | US$148.43m |
Total liabilities | US$10.69m |
Total assets | US$159.12m |
Recent financial health updates
Will Talaris Therapeutics (NASDAQ:TALS) Spend Its Cash Wisely?
May 24Is Talaris Therapeutics (NASDAQ:TALS) In A Good Position To Invest In Growth?
Feb 14We're Keeping An Eye On Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate
Oct 21We're Not Very Worried About Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate
Jul 06Talaris Therapeutics (NASDAQ:TALS) Is In A Good Position To Deliver On Growth Plans
Mar 23Recent updates
Will Talaris Therapeutics (NASDAQ:TALS) Spend Its Cash Wisely?
May 24Is Talaris Therapeutics (NASDAQ:TALS) In A Good Position To Invest In Growth?
Feb 14We're Keeping An Eye On Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate
Oct 21Talaris drops 24% after patient death in late-stage trial for lead asset
Oct 20Talaris Therapeutics: Plenty Of Upside Remains, But So Does The Risk
Aug 29Talaris Therapeutics GAAP EPS of -$0.44
Aug 15We're Not Very Worried About Talaris Therapeutics' (NASDAQ:TALS) Cash Burn Rate
Jul 06Talaris Therapeutics achieves positive results in phase 3 kidney transplant drug trial
Jun 30Talaris Therapeutics (NASDAQ:TALS) Is In A Good Position To Deliver On Growth Plans
Mar 23Talaris Therapeutics EPS beats by $0.49
Jun 14Financial Position Analysis
Short Term Liabilities: TALS's short term assets ($156.2M) exceed its short term liabilities ($10.1M).
Long Term Liabilities: TALS's short term assets ($156.2M) exceed its long term liabilities ($555.0K).
Debt to Equity History and Analysis
Debt Level: TALS is debt free.
Reducing Debt: TALS has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TALS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TALS has sufficient cash runway for 2.5 years if free cash flow continues to reduce at historical rates of 36.8% each year.